Philip E. Johnson
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 8
- Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques 40
- DNA and Nucleic Acid Chemistry 18
- RNA and protein synthesis mechanisms 14
- RNA modifications and cancer 8
- Biotechnology top 1%
- Enzyme Production and Characterization 9
- Infectious Diseases top 2%
-
- Molecular Junctions and Nanostructures 10
-
- Mass Spectrometry Techniques and Applications 9
Philip E. Johnson
146 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 948
- Pediatrics, Perinatology and Child Health 1.2k
- Molecular Biology 3.4k
- Biotechnology 360
- Infectious Diseases 583
Countries citing papers authored by Philip E. Johnson
This map shows the geographic impact of Philip E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Johnson more than expected).
Fields of papers citing papers by Philip E. Johnson
This network shows the impact of papers produced by Philip E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Johnson. The network helps show where Philip E. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2021 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2013 | 1 | |
| 13 | 2012 | 5 | |
| 14 | 2009 | 14 | |
| 15 | Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. | 2002 | 206 |
| 16 | 1999 | 85 | |
| 17 | 1998 | 21 | |
| 18 | 1996 | 16 | |
| 19 | Dietary zinc affects the amount of molecular distribution of zinc in endogenous secretions | 1991 | 1 |
| 20 | Accumulation of mercury and other elements by Spirulina (Cyanophyceae) | 1986 | 14 |
About Philip E. Johnson
Philip E. Johnson is a scholar working on Geriatrics and Gerontology, Molecular Biology, Biotechnology, Occupational Therapy and Family Practice, having authored 149 papers that have together received 6.2k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (40 papers), DNA and Nucleic Acid Chemistry (18 papers), RNA and protein synthesis mechanisms (14 papers), Molecular Junctions and Nanostructures (10 papers), Enzyme Production and Characterization (9 papers), Mass Spectrometry Techniques and Applications (9 papers), Cancer Genomics and Diagnostics (8 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (948 citations), Pediatrics, Perinatology and Child Health (1.2k citations), Molecular Biology (3.4k citations), Biotechnology (360 citations) and Infectious Diseases (583 citations). Philip E. Johnson has collaborated with scholars based in Canada, United States and Hong Kong. Frequent co-authors include Yuk Ming Dennis Lo, N M Hjelm, Tze Kin Lau, Priscilla M.K. Poon, James S. Wainscoat, Allan Chang, Tse Ngong Leung, Mark Tein, Christopher J. Haines and Paul B.S. Lai. Their work appears in journals such as Biochemistry, American Journal of Health-System Pharmacy, ChemBioChem, Annals of the New York Academy of Sciences and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.